Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Apidra, Ontak, Raptiva
Link ID 12197
Title FDA Safety Changes: Apidra, Ontak, Raptiva
Url http://www.medscape.com/viewarticle/586306?src=rss
Description The FDA has approved revisions to the safety labeling for insulin glulisine [rDNA origin] injection (Apidra), denileukin diftitox (Ontak), and efalizumab (Raptiva). Medscape Medical News
Category Articles > Allergy and Clinical Immunology
Keywords
Date Jan 7, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. Updated Recommendations for Use of Hib Booster Vaccine As Supplies Increase
  The final dose of the Hib booster vaccination series is being given to those children between the age of 15 months and before their fifth birthday who have already received the primary series. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


2. Sublingual Immunotherapy Helps Prevent Asthma in Children With Allergic Rhinitis
  In children with allergic rhinitis, sublingual immunotherapy (SLIT) can help prevent mild persistent asthma and new skin sensitizations and can reduce bronchial hyperactivity, Italian researchers report. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


3. Azelastine Plus Fluticasone Nasal Spray Effective for Seasonal Allergic Rhinitis
  Combination therapy with azelastine and fluticasone nasal sprays was more effective for sneezing, itchy nose, runny nose, and nasal congestion vs therapy with either agent alone. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology


4. Rituximab-Induced Changes in Hematolymphoid Tissues Found at Autopsy
  Clinical charts, autopsy records, lymph node and spleen sections, were reviewed from 10 patients who had received 1 to 40 doses of rituximab before death.
American Journal of Clinical Pathology
Category:   Articles > Allergy and Clinical Immunology


5. The Ongoing Challenge of Financing Medical Education
  Eli Y. Adashi, MD, MS, FACOG, Professor of Medical Sciences and Outgoing Dean of Medicine and Biological Sciences at Brown University, discusses the growing cost of medical education. Medscape Internal Medicine
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS